0001179110-13-017667.txt : 20131210
0001179110-13-017667.hdr.sgml : 20131210
20131210161528
ACCESSION NUMBER: 0001179110-13-017667
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131206
FILED AS OF DATE: 20131210
DATE AS OF CHANGE: 20131210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 119 FOURTH AVE
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: 7814330771
MAIL ADDRESS:
STREET 1: 119 FOURTH AVE
CITY: NEEDHAM
STATE: MA
ZIP: 02494-2725
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CATLIN AVERY W
CENTRAL INDEX KEY: 0001255348
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15006
FILM NUMBER: 131268602
MAIL ADDRESS:
STREET 1: 241 CENTRAL STREET
CITY: HINGHAM
STATE: MA
ZIP: 02043
4
1
edgar.xml
FORM 4 -
X0306
4
2013-12-06
0
0000744218
Celldex Therapeutics, Inc.
CLDX
0001255348
CATLIN AVERY W
C/O CELLDEX THERAPEUTICS, INC.
119 FOURTH AVENUE
NEEDHAM
MA
02494
0
1
0
0
Sr. VP & CFO
Common Stock
2013-12-06
4
M
0
183333
8.16
A
197442
D
Common Stock
2013-12-06
4
S
0
183333
24.50
D
14109
D
Incentive Stock Option
8.16
2013-12-06
4
M
0
49016
0
D
2009-03-07
2015-03-07
Common Stock
49016
134317
D
Non-Qualified Stock Option
8.16
2013-12-06
4
M
0
134317
0
D
2009-03-07
2015-03-07
Common Stock
134317
0
D
The option vested in four equal annual installments on March 7, 2009, March 7, 2010, March 7, 2011 and March 7,2012.
The option vested in four annual installments. 33,580 shares on March 7, 2009 and 33,579 shares on March 7, 2010, March 7, 2011 and March 7, 2012.
/s/ Anthony S. Marucci, attorney in fact for Avery W. Catlin
2013-12-10